News

Latest news

22nd October 2024

当社のご紹介 2024年10月

Read more
22nd October 2024

創薬のプリズムバイオラボに熱視線　メガファーマも評価 （日本経済新聞掲載）

Read more
22nd October 2024

EPICS Therapeutics Appoints Graeme Fraser PhD, Chief Executive Officer and Raises €12M in Series A Preferred Financing to Advance its Oncology Pipeline

Read more
23rd September 2024

SYNERGIA MEDICAL SUCCESSFULLY IMPLANTS FIRST PATIENTS WITH NAO.VNS(TM)

Read more
27th May 2024

東京証券取引所グロース市場への上場承認に関するお知らせ

Read more
15th May 2024

Presentation of the main results of the phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024

Read more
16th April 2024

Acticor Biotech will present the clinical results of its phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024

Read more
22nd March 2024

SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT

Read more
15th March 2024

Acticor Biotech completes a capital increase for a total gross amount of 8 million euros

Read more